메뉴 건너뛰기




Volumn 50, Issue 2, 2016, Pages 311-322

The treatment of behavioral disturbances and psychosis associated with dementia;Terapia zaburzeń behawioralnych i psychoz towarzyszaçych otȩpieniu

Author keywords

Behavioral Disturbances; Dementia; Psychosis

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; DONEPEZIL; FIRST GENERATION ANTIPSYCHOTIC; GABAPENTIN; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PARACETAMOL; PLACEBO; PRAZOSIN; QUETIAPINE; RISPERIDONE; SECOND GENERATION ANTIPSYCHOTIC; TRAZODONE; UNCLASSIFIED DRUG; VALPROIC ACID;

EID: 84978891171     PISSN: 00332674     EISSN: 23915854     Source Type: Journal    
DOI: 10.12740/PP/60904     Document Type: Review
Times cited : (9)

References (44)
  • 2
    • 84875859346 scopus 로고    scopus 로고
    • Agitation and aggression in people with Alzheimers disease
    • Ballard C, Corbett A. Agitation and aggression in people with Alzheimers disease. Curr. Opin. Psychiatry 2013; 26(3): 252-259.
    • (2013) Curr. Opin. Psychiatry , vol.26 , Issue.3 , pp. 252-259
    • Ballard, C.1    Corbett, A.2
  • 3
    • 46749095495 scopus 로고    scopus 로고
    • Clinical symptom responses to atypical antipsychotic medications in Alzheimers disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
    • Sultzer DL, Davis SM, Tariot PN, Dagerman KS, Lebowitz BD, Lyketsos CG. et al. Clinical symptom responses to atypical antipsychotic medications in Alzheimers disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am. J. Psychiatry 2008; 165(7): 844-854.
    • (2008) Am. J. Psychiatry , vol.165 , Issue.7 , pp. 844-854
    • Sultzer, D.L.1    Davis, S.M.2    Tariot, P.N.3    Dagerman, K.S.4    Lebowitz, B.D.5    Lyketsos, C.G.6
  • 4
    • 84861936838 scopus 로고    scopus 로고
    • Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: A systematic review
    • Pratt N, Roughhead EE, Salter A, Ryan P. Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: A systematic review. BMC Med. Res. Methodol. 2012; 12: 72.
    • (2012) BMC Med. Res. Methodol , vol.12 , pp. 72
    • Pratt, N.1    Roughhead, E.E.2    Salter, A.3    Ryan, P.4
  • 6
    • 33745737632 scopus 로고    scopus 로고
    • Neuroleptic drugs in dementia: Benefits and harm
    • Ballard C, Howard R. Neuroleptic drugs in dementia: benefits and harm. Nat. Rev. Neurosci. 2006; 7(6):492-500.
    • (2006) Nat. Rev. Neurosci , vol.7 , Issue.6 , pp. 492-500
    • Ballard, C.1    Howard, R.2
  • 8
    • 0033799993 scopus 로고    scopus 로고
    • Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial
    • Street JS, Clark WS, Gannon KS, Cummings JL, Bymaster FP, Tamura RN. et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch. Gen. Psychiatry 2000; 57(10): 968-976.
    • (2000) The HGEU Study Group. Arch. Gen. Psychiatry , vol.57 , Issue.10 , pp. 968-976
    • Street, J.S.1    Clark, W.S.2    Gannon, K.S.3    Cummings, J.L.4    Bymaster, F.P.5    Tamura, R.N.6
  • 9
    • 33644922637 scopus 로고    scopus 로고
    • Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-Analysis of randomized, placebo-controlled trials
    • Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-Analysis of randomized, placebo-controlled trials. Am. J. Geriatr. Psychiatry 2006; 14(3): 191-210.
    • (2006) Am. J. Geriatr. Psychiatry , vol.14 , Issue.3 , pp. 191-210
    • Schneider, L.S.1    Dagerman, K.2    Insel, P.S.3
  • 10
    • 0032966714 scopus 로고    scopus 로고
    • Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial
    • Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. Risperidone Study Group. J. Clin. Psychiatry 1999; 60(2): 107-115.
    • (1999) Risperidone Study Group. J. Clin. Psychiatry , vol.60 , Issue.2 , pp. 107-115
    • Katz, I.R.1    Jeste, D.V.2    Mintzer, J.E.3    Clyde, C.4    Napolitano, J.5    Brecher, M.6
  • 11
    • 26844538114 scopus 로고    scopus 로고
    • Risk of death with atypical antipsychotics drug treatment for dementia: Meta-Analysis of randomized placebo-controlled trials
    • Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotics drug treatment for dementia: meta-Analysis of randomized placebo-controlled trials. JAMA 2012; 294(15): 1934-1943.
    • (2012) JAMA , vol.294 , Issue.15 , pp. 1934-1943
    • Schneider, L.S.1    Dagerman, K.S.2    Insel, P.3
  • 12
    • 28244431743 scopus 로고    scopus 로고
    • Risk of death in elderly users of conventional vs atypical antipsychotic medications
    • Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH. et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N. Engl. J. Med. 2005; 353(22): 2335-2341.
    • (2005) N. Engl. J. Med , vol.353 , Issue.22 , pp. 2335-2341
    • Wang, P.S.1    Schneeweiss, S.2    Avorn, J.3    Fischer, M.A.4    Mogun, H.5    Solomon, D.H.6
  • 15
    • 0035674311 scopus 로고    scopus 로고
    • A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients
    • Chan WC, Lam LC, Choy CN, Leung VP, Li SW, Chiu HF. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int. J. Geriatr. Psychiatry 2001; 16(12): 1156-1162.
    • (2001) Int. J. Geriatr. Psychiatry , vol.16 , Issue.12 , pp. 1156-1162
    • Chan, W.C.1    Lam, L.C.2    Choy, C.N.3    Leung, V.P.4    Li, S.W.5    Chiu, H.F.6
  • 16
    • 80053215800 scopus 로고    scopus 로고
    • Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-Analysis
    • 12
    • Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B. et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-Analysis. JAMA 2011; 28; 306(12): 1359-1369.
    • (2011) JAMA , vol.28 , Issue.306 , pp. 1359-1369
    • Maher, A.R.1    Maglione, M.2    Bagley, S.3    Suttorp, M.4    Hu, J.H.5    Ewing, B.6
  • 17
    • 34447118214 scopus 로고    scopus 로고
    • Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-Adrenoceptors in patients with Alzheimer disease
    • Sharp SI, Ballard CG, Chen CP, Francis PT. Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-Adrenoceptors in patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 2007; 15(5): 435-437.
    • (2007) Am. J. Geriatr. Psychiatry , vol.15 , Issue.5 , pp. 435-437
    • Sharp, S.I.1    Ballard, C.G.2    Chen, C.P.3    Francis, P.T.4
  • 19
    • 69449092485 scopus 로고    scopus 로고
    • Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression
    • Wang LY, Shofer JB, Rohde K, Hart KL, Hoff DJ, McFall YH. et al. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am. J. Geriatr. Psychiatry 2009; 17(9): 744-751.
    • (2009) Am. J. Geriatr. Psychiatry , vol.17 , Issue.9 , pp. 744-751
    • Wang, L.Y.1    Shofer, J.B.2    Rohde, K.3    Hart, K.L.4    Hoff, D.J.5    McFall, Y.H.6
  • 20
    • 0033945096 scopus 로고    scopus 로고
    • A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias
    • Hawkins JW, Tinklenberg JR, Sheikh JI, Peyser CE, Yesavage JA. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. Am. J. Geriatr. Psychiatry 2000; 8(3): 221-225.
    • (2000) Am. J. Geriatr. Psychiatry , vol.8 , Issue.3 , pp. 221-225
    • Hawkins, J.W.1    Tinklenberg, J.R.2    Sheikh, J.I.3    Peyser, C.E.4    Yesavage, J.A.5
  • 21
    • 0346848738 scopus 로고    scopus 로고
    • Gabapentin for the treatment of behavioural alterations in dementia: Preliminary 15-month investigation
    • Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation. Drugs Aging 2003; 20(14): 1035-1040.
    • (2003) Drugs Aging , vol.20 , Issue.14 , pp. 1035-1040
    • Moretti, R.1    Torre, P.2    Antonello, R.M.3    Cazzato, G.4    Bava, A.5
  • 22
    • 0028970069 scopus 로고
    • Anticonvulsants attenuate amyloid betapeptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology
    • Mark RJ, Ashford JW, Goodman Y, Mattson MP. Anticonvulsants attenuate amyloid betapeptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology. Neurobiol. Aging 1995; 16(2): 187-198.
    • (1995) Neurobiol. Aging , vol.16 , Issue.2 , pp. 187-198
    • Mark, R.J.1    Ashford, J.W.2    Goodman, Y.3    Mattson, M.P.4
  • 24
    • 41649103102 scopus 로고    scopus 로고
    • American Psychiatric Association practice guideline for the treatment of patients with Alzheimers disease and other dementias
    • APA Work Group on Alzheimers Disease and other Dementias
    • APA Work Group on Alzheimers Disease and other Dementias, Rabins PV, Blacker D, Rovner BW, Rummans T, Schneider LS. et al. American Psychiatric Association practice guideline for the treatment of patients with Alzheimers disease and other dementias. Second edition. Am. J. Psychiatry 2007; 164(12 supl.): 5-56.
    • (2007) Second Edition. Am. J. Psychiatry , vol.164 , Issue.12 , pp. 5-56
    • Rabins, P.V.1    Blacker, D.2    Rovner, B.W.3    Rummans, T.4    Schneider, L.S.5
  • 26
    • 0036085791 scopus 로고    scopus 로고
    • Sodium valproate in the treatment of aggressive behavior in patients with dementia-A randomized placebo controlled clinical trial
    • Sival RC, Haffmans PM, Jansen PA, Duursma SA, Eikelenboom P. Sodium valproate in the treatment of aggressive behavior in patients with dementia-A randomized placebo controlled clinical trial. Int. J. Geriatr. Psychiatry 2002; 17(6): 579-585.
    • (2002) Int. J. Geriatr. Psychiatry , vol.17 , Issue.6 , pp. 579-585
    • Sival, R.C.1    Haffmans, P.M.2    Jansen, P.A.3    Duursma, S.A.4    Eikelenboom, P.5
  • 27
    • 0031944188 scopus 로고    scopus 로고
    • Serotonin in aging, late-life depression, and Alzheimers disease: The emerging role of functional imaging
    • Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, Moore RY. et al. Serotonin in aging, late-life depression, and Alzheimers disease: The emerging role of functional imaging. Neuropsychopharmacology 1998; 18(6): 407-430.
    • (1998) Neuropsychopharmacology , vol.18 , Issue.6 , pp. 407-430
    • Meltzer, C.C.1    Smith, G.2    DeKosky, S.T.3    Pollock, B.G.4    Mathis, C.A.5    Moore, R.Y.6
  • 28
    • 84894122063 scopus 로고    scopus 로고
    • Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial
    • Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z. et al. Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial. JAMA 2014; 311(7): 682-691.
    • (2014) JAMA , vol.311 , Issue.7 , pp. 682-691
    • Porsteinsson, A.P.1    Drye, L.T.2    Pollock, B.G.3    Devanand, D.P.4    Frangakis, C.5    Ismail, Z.6
  • 29
    • 0036190759 scopus 로고    scopus 로고
    • Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients
    • Pollock BG, Mulsant BH, Rosen J, Sweet RA, Mazumdar S, Bharucha A. et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am. J. Psychiatry 2002; 159(3): 460-465.
    • (2002) Am. J. Psychiatry , vol.159 , Issue.3 , pp. 460-465
    • Pollock, B.G.1    Mulsant, B.H.2    Rosen, J.3    Sweet, R.A.4    Mazumdar, S.5    Bharucha, A.6
  • 30
    • 38449107464 scopus 로고    scopus 로고
    • A doubleblind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia
    • Pollock BG, Mulsant BH, Rosen J, Mazumdar S, Blakesley RE, Houck PR. et al. A doubleblind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am. J. Geriatr. Psychiatry 2007; 15(11): 942-952.
    • (2007) Am. J. Geriatr. Psychiatry , vol.15 , Issue.11 , pp. 942-952
    • Pollock, B.G.1    Mulsant, B.H.2    Rosen, J.3    Mazumdar, S.4    Blakesley, R.E.5    Houck, P.R.6
  • 31
    • 0031026215 scopus 로고    scopus 로고
    • A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia
    • Sultzer DL, Gray KF, Gunay I, Berisford MA, Mahler ME. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am. J. Geriatr. Psychiatry 1997; 5(1): 60-69.
    • (1997) Am. J. Geriatr. Psychiatry , vol.5 , Issue.1 , pp. 60-69
    • Sultzer, D.L.1    Gray, K.F.2    Gunay, I.3    Berisford, M.A.4    Mahler, M.E.5
  • 32
    • 0034649447 scopus 로고    scopus 로고
    • Treatment of agitation in AD: A randomized, placebo-controlled clinical trial
    • Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE. et al. Treatment of agitation in AD: A randomized, placebo-controlled clinical trial. Neurology 2000; 55(9): 1271-1278.
    • (2000) Neurology , vol.55 , Issue.9 , pp. 1271-1278
    • Teri, L.1    Logsdon, R.G.2    Peskind, E.3    Raskind, M.4    Weiner, M.F.5    Tractenberg, R.E.6
  • 33
    • 0033980910 scopus 로고    scopus 로고
    • Cholinesterase inhibitors: A new class of psychotropic compounds
    • Cummings JL. Cholinesterase inhibitors: A new class of psychotropic compounds. Am. J. Psychiatry 2000; 157(1): 4-15.
    • (2000) Am. J. Psychiatry , vol.157 , Issue.1 , pp. 4-15
    • Cummings, J.L.1
  • 35
    • 3242775357 scopus 로고    scopus 로고
    • The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease
    • Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A. et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology 2004; 63(2): 214-219.
    • (2004) Neurology , vol.63 , Issue.2 , pp. 214-219
    • Holmes, C.1    Wilkinson, D.2    Dean, C.3    Vethanayagam, S.4    Olivieri, S.5    Langley, A.6
  • 36
    • 38049005871 scopus 로고    scopus 로고
    • Efficacy of memantine on behavioral and psychological symptoms related to dementia: A systematic meta-Analysis
    • Maidment ID, Fox CG, Boustani M, Rodriguez J, Brown RC, Katona CL. Efficacy of memantine on behavioral and psychological symptoms related to dementia: A systematic meta-Analysis. Ann. Pharmacother. 2008; 42(1): 32-38.
    • (2008) Ann. Pharmacother , vol.42 , Issue.1 , pp. 32-38
    • Maidment, I.D.1    Fox, C.G.2    Boustani, M.3    Rodriguez, J.4    Brown, R.C.5    Katona, C.L.6
  • 37
    • 19144372322 scopus 로고    scopus 로고
    • Effects of memantine on behavioural symptoms in Alzheimers disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
    • Gauthier S, Wirth Y, Möbius HJ. Effects of memantine on behavioural symptoms in Alzheimers disease patients: An analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int. J. Geriatr. Psychiatry 2005; 20(5): 459-464.
    • (2005) Int. J. Geriatr. Psychiatry , vol.20 , Issue.5 , pp. 459-464
    • Gauthier, S.1    Wirth, Y.2    Möbius, H.J.3
  • 38
    • 42249111378 scopus 로고    scopus 로고
    • Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimers disease: A pooled analysis of 3 studies
    • Wilcock GK, Ballard CG, Cooper JA, Loft H. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimers disease: A pooled analysis of 3 studies. J. Clin. Psychiatry 2008; 69(3): 341-348.
    • (2008) J. Clin. Psychiatry , vol.69 , Issue.3 , pp. 341-348
    • Wilcock, G.K.1    Ballard, C.G.2    Cooper, J.A.3    Loft, H.4
  • 39
    • 29244481938 scopus 로고    scopus 로고
    • Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-To-severe dementia
    • Chibnall JT, Tait RC, Harman B, Luebbert RA. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-To-severe dementia. J. Am. Geriatr. Soc. 2005; 53(11): 1921-1929.
    • (2005) J. Am. Geriatr. Soc , vol.53 , Issue.11 , pp. 1921-1929
    • Chibnall, J.T.1    Tait, R.C.2    Harman, B.3    Luebbert, R.A.4
  • 40
    • 4344621472 scopus 로고    scopus 로고
    • Pain assessment and management in persons with dementia
    • Horgas AL, Elliott AF. Pain assessment and management in persons with dementia. Nurs. Clin. North Am. 2004; 39(3): 593-606.
    • (2004) Nurs. Clin. North Am , vol.39 , Issue.3 , pp. 593-606
    • Horgas, A.L.1    Elliott, A.F.2
  • 41
    • 40549112334 scopus 로고    scopus 로고
    • ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia
    • Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider L. et al. ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2008; 33(5): 957-970.
    • (2008) Neuropsychopharmacology , vol.33 , Issue.5 , pp. 957-970
    • Jeste, D.V.1    Blazer, D.2    Casey, D.3    Meeks, T.4    Salzman, C.5    Schneider, L.6
  • 42
    • 12844274439 scopus 로고    scopus 로고
    • Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence
    • Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. JAMA 2005; 293(5): 596-608.
    • (2005) JAMA , vol.293 , Issue.5 , pp. 596-608
    • Sink, K.M.1    Holden, K.F.2    Yaffe, K.3
  • 44
    • 46749128245 scopus 로고    scopus 로고
    • Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy
    • Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J, Grossberg GT. et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J. Clin. Psychiatry 2008; 69(6): 889-898.
    • (2008) J. Clin. Psychiatry , vol.69 , Issue.6 , pp. 889-898
    • Salzman, C.1    Jeste, D.V.2    Meyer, R.E.3    Cohen-Mansfield, J.4    Cummings, J.5    Grossberg, G.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.